Last $102.40 USD
Change Today 0.00 / 0.00%
Volume 348.8K
TFX On Other Exchanges
New York
As of 8:04 PM 04/15/14 All times are local (Market data is delayed by at least 15 minutes).

teleflex inc (TFX) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/4/14 - $109.73
52 Week Low
06/24/13 - $73.83
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TELEFLEX INC (TFX)

Related News

No related news articles were found.

teleflex inc (TFX) Related Businessweek News

No Related Businessweek News Found

teleflex inc (TFX) Details

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company operates in three segments: Vascular, Anesthesia/Respiratory, and Surgical. It offers vascular access products that facilitate various critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and taking of blood samples through a single puncture site; anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand; respiratory care products, such as oxygen therapy, aerosol therapy, spirometry, and ventilation management products under the Hudson RCI brand; and specialty products, including interventional access products, and products provided to specialty market customers. The company also provides surgical products, such as ligation and closure products used in surgical procedures; access ports for use in minimally invasive surgical procedures; fluid management products for use in chest drainage; and reusable hand-held instruments for general and specialty surgical procedures under the Deknatel, Pilling, Pleur-evac, Taut, and Weck brands. In addition, it offers cardiac care products comprising diagnostic catheters, including thermodilution and wedge pressure catheters; angiographic and therapeutic delivery catheters; sheaths for femoral and trans-radial aortic access, and intra-aortic balloons; and capital equipment, such as intra-aortic balloon pumps under the Arrow brand. Further, the company provides original equipment manufacturing and development services. Teleflex Incorporated offers its products to hospitals and healthcare providers in approximately 150 countries through its direct sales force and distributors. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

11,400 Employees
Last Reported Date: 02/24/14
Founded in 1943

teleflex inc (TFX) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $826.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $441.5K
Executive Vice President and President of Ame...
Total Annual Compensation: $427.1K
Compensation as of Fiscal Year 2013.

teleflex inc (TFX) Key Developments

Teleflex Incorporated Enters into Amendment to Credit Agreement; Promotes Liam Kelly as Executive Vice President and President, Americas

Teleflex Incorporated, JPMorgan Chase Bank, N.A. and certain lenders under its credit agreement, dated as of July 16, 2013, with JPMorgan Chase Bank, N.A., as administrative agent, the guarantors party thereto, the lenders party thereto and each other party thereto entered into a consent and amendment No. 1 to, among other things, (1) permit certain transactions related to the corporate integration of the business of Vidacare Corporation and (2) increase certain financial ratios relevant to the ability of Teleflex Incorporated and its subsidiaries to make intercompany loans to and investments in entities which are not guarantors under the credit agreement. The company promoted Liam Kelly, previously its Executive Vice President and President, International, to the position of Executive Vice President and President, Americas.

Teleflex Incorporated Announces FDA 510(k) Clearance for Restated Indications for Use of EZ-IO(R) Vascular Access System

Teleflex Incorporated announced FDA 510(k) clearance for restated Indications for Use of the EZ-IO(R) Vascular Access System. The EZ-IO(R) 25 mm Needle Set is now indicated for patients 3 kg or over. Teleflex recently announced its acquisition of Vidacare Corporation, developer of the EZ-IO(R) Vascular Access System. Vidacare is a provider of intraosseous (IO), or inside the bone access devices. New weight ranges for the EZ-IO(R) Vascular Access System are now as follows: EZ-IO(R) 45 mm Needle with Weight Classification of 40 kg or over; EZ-IO(R) 25 mm Needle with Weight Classification of 3 kg or over; EZ-IO(R) 15 mm Needle with Weight Classification of 3 -- 39 kg.

Teleflex Incorporated Accepts Retirement of James W. Zugs from the Board

Teleflex Incorporated announced that on February 19, 2014, the Board of Directors of the company accepted James W. Zugs offer to retire from the Board, effective as of the date of the company's 2014 annual meeting of stockholders. In connection with Mr. Zugs retirement, the Board approved a decrease in the size of the Board from eleven to ten directors, effective upon Mr. Zugs retirement.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TFX:US $102.40 USD 0.00

TFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Carpenter Technology Corp $62.95 USD -0.38
Crane Co $68.43 USD -0.27
PerkinElmer Inc $44.03 USD -0.09
Sirona Dental Systems Inc $74.46 USD +0.45
STERIS Corp $49.84 USD +0.27
View Industry Companies

Industry Analysis


Industry Average

Valuation TFX Industry Range
Price/Earnings 29.6x
Price/Sales 2.5x
Price/Book 2.2x
Price/Cash Flow 28.0x
TEV/Sales 1.5x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TELEFLEX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at